Genfit SA (GNFT)
4.535
-0.68
(-12.96%)
USD |
NASDAQ |
Nov 14, 16:00
4.535
0.00 (0.00%)
After-Hours: 20:00
Genfit Gross Profit (Annual): 30.56M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.56M |
| December 31, 2022 | 21.03M |
| December 31, 2021 | 94.54M |
| December 31, 2020 | 0.643M |
| December 31, 2019 | 34.33M |
| December 31, 2018 | -0.0673M |
| December 31, 2017 | 0.0068M |
| December 31, 2016 | -1.883M |
| December 31, 2015 | -1.558M |
| December 31, 2014 | 0.2779M |
| Date | Value |
|---|---|
| December 31, 2013 | 0.8054M |
| December 31, 2012 | 0.6135M |
| December 31, 2011 | 1.324M |
| December 31, 2010 | 3.166M |
| December 31, 2009 | 5.866M |
| December 31, 2008 | 9.526M |
| December 31, 2007 | 10.24M |
| December 31, 2006 | 10.51M |
| December 31, 2005 | 14.26M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
0.643M
Minimum
2020
94.54M
Maximum
2021
36.22M
Average
30.56M
Median
2023
Gross Profit (Annual) Benchmarks
| Edap TMS SA | 26.43M |
| Cellectis SA | 0.018M |
| Ascendis Pharma AS | 240.69M |
| Adaptimmune Therapeutics PLC | -- |
| Akari Therapeutics PLC | -- |